Ovarian Cancer Immunotherapy
- Publisher's listprice GBP 120.00
-
57 330 Ft (54 600 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 5 733 Ft off)
- Discounted price 51 597 Ft (49 140 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
57 330 Ft
Availability
Estimated delivery time: Expected time of arrival: end of January 2026.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP USA
- Date of Publication 22 November 2018
- ISBN 9780190248208
- Binding Hardback
- No. of pages272 pages
- Size 183x257x20 mm
- Weight 757 g
- Language English 0
Categories
Short description:
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences, and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more.
MoreLong description:
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences, and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more. Readers will also gain a better understanding of the molecular and cellular events that underlie ovarian cancer immunology. This book is an ideal resource for clinicians, basic medical scientists, graduate basic medical science students, and medical students caring for patients with ovarian cancer, including attending surgeons and physicians, and clinical fellows and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology.
MoreTable of Contents:
Chapter 1: Antibody Therapeutics for Ovarian Carcinoma and Translation to the Clinic
Debra H. Josephs, Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. Karagiannis
Chapter 2: Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian Cancer
Rouba Ali- Fehmi and Eman Abdulfatah
Chapter 3: Ovarian Cancer Immunity: How Does Immune Suppression Grow Cancer?
Vincent Lavoué, Patrick Legembre, Jean Levêque, Fabrice Foucher, Sébastien Henno, and Florian Cabillic
Chapter 4: Ovarian Tumor Microenvironment and Innate Immune Recognition
Jocelyn Reader, Sarah Lynam, Amy Harper, Gautam Rao, Maya Matheny, and Dana M. Roque
Chapter 5: Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer
Samir A. Farghaly
Chapter 6: Antibody-based Therapy for Ovarian Cancer
Yousef Alharbi, Manish S. Patankar, and Rebecca J. Whelan
Chapter 7: Epitope/Peptide-based Monoclonal Antibodies for Immunotherapy of Ovarian Cancer
Gregory Lee
Chapter 8: Dendritic Cell Vaccine Therapy for Ovarian Cancer
Caitlin Stashwick, Brian J. Czerniecki, Janos L. Tanyi
Chapter 9: Heat Shock Protein Vaccine Therapy for Ovarian Cancer
Hiroyuki Abe, Amane Sasada, Shigeki Tabata, and Minako Abe
Chapter 10: PD-1 /PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer
Scott Moerdler and Xingxing Zang
Chapter 11: Growth Factors and Their Corresponding Receptors as Targets for Ovarian Cancer Therapy
Anca Maria Cimpean, Andreea Adriana Jitariu, and Marius Raica
Chapter 12: Unique Challenges Facing Immunotherapy of Metastatic Ovarian Cancer
Michelle N. Messmer, Colleen S. Netherby, and Scott I. Abrams
Chapter 13: Clinical Trials of Ovarian Cancer Immunotherapy and Future Directions
Justin M. Drerup, Curtis A. Clark, and Tyler J. Curiel
